. "T\u011Bhotenstv\u00ED\nAdekv\u00E1tn\u00ED \u00FAdaje o pod\u00E1v\u00E1n\u00ED p\u0159\u00EDpravku VIGAMOX O\u010CN\u00CD KAPKY t\u011Bhotn\u00FDm \u017Een\u00E1m nejsou k\u00A0dispozici. Nep\u0159edpokl\u00E1daj\u00ED se v\u0161ak \u017E\u00E1dn\u00E9 \u00FA\u010Dinky na t\u011Bhotenstv\u00ED, proto\u017Ee syst\u00E9mov\u00E1 expozice moxifloxacinem je zanedbateln\u00E1. VIGAMOX O\u010CN\u00CD KAPKY se m\u016F\u017Ee pou\u017E\u00EDvat i v\u00A0pr\u016Fb\u011Bhu t\u011Bhotenstv\u00ED.\nKojen\u00ED\nNen\u00ED zn\u00E1mo, zda se moxifloxacin vylu\u010Duje do mate\u0159sk\u00E9ho ml\u00E9ka. Studie na zv\u00ED\u0159atech prok\u00E1zaly exkreci n\u00EDzk\u00FDch \u00FArovn\u00ED do mate\u0159sk\u00E9ho ml\u00E9ka po or\u00E1ln\u00EDm pod\u00E1n\u00ED moxifloxacinu. P\u0159i terapeutick\u00FDch d\u00E1vk\u00E1ch p\u0159\u00EDpravku VIGAMOX O\u010CN\u00CD KAPKY se v\u0161ak \u017E\u00E1dn\u00E9 \u00FA\u010Dinky na kojen\u00E9 d\u00EDt\u011B neo\u010Dek\u00E1vaj\u00ED. VIGAMOX O\u010CN\u00CD KAPKY m\u016F\u017Ee b\u00FDt pou\u017E\u00EDv\u00E1n i v\u00A0pr\u016Fb\u011Bhu kojen\u00ED.\n"@cs . "004.006" . . "4.6 T\u011Bhotenstv\u00ED a kojen\u00ED"@cs . . . .